Live stock market analysis since 1992. service@briefing.com | 800-752-3013

Joined September 2009
2,109 Photos and videos
Pinned Tweet
Tech and AI leadership have been under pressure, but dip buyers are trying to step back in. The question now is whether the rebound has enough support or if leadership continues to rotate beneath the surface. Briefing Investor helps active investors stay focused on what’s moving, what’s rotating, and what matters next. Get 50% off: briefing.com/premium-service… #StockMarket #Investing #Trading #Markets #MarketAnalysis
1,248
$ADBE: Adobe is trading sharply lower despite a Q2 beat-and-raise, as investors focus on lower second-half ARR expectations tied to its freemium and AI engagement push. The stock now needs proof that AI usage and larger user funnels can convert into durable ARR growth. See the full analysis: briefing.com/story-stocks/ar… #Adobe #earnings #Software #AI #ARR #CFO #stocks #storystocks
761
$LEN: Lennar’s margin story is improving, with Q3 gross margin guided near 16%, but demand remains the harder part of the setup. Elevated rates, affordability pressure, softer orders, lower ASPs, and high incentives are still limiting the case for a cleaner housing rebound. See the full analysis: briefing.com/story-stocks/ar… #Lennar #earnings #homebuilders #housing #stocks #investing
2
812
$ADBE: Adobe -9.5% premarket despite beating Q2 estimates and guiding Q3/FY26 above consensus. Investors are focused on lowered ARR guidance, a CFO departure, and downgrades from Stifel, Evercore ISI, and Wolfe.
1
1
896
$AMD: Advanced Micro Devices upgraded to Buy from Neutral at Citigroup, tgt $575 briefing.com/calendars/updow…

1
733
$SPCX: SpaceX initiated with an Outperform at Wolfe Research; tgt $175 briefing.com/calendars/updow…

2
803
$LEN: Lennar reported EPS in line, missed revenue expectations, reported a 2% increase in year-over-year deliveries, and expects Q3 deliveries to be between 21,000 and 22,000.
1
642
$ADBE: Adobe (-8.2%) beat EPS expectations by $0.14, beat revenue expectations, guided Q3 revenues above consensus, and guided FY26 EPS and revenues above consensus. The company's CFO is departing for a chipmaking company.
1
1
911
The market is building on yesterday’s rally as lower oil, easing geopolitical risk, and renewed semiconductor strength improve sentiment. SpaceX’s record IPO adds another major catalyst, but also raises the question of whether investors will fund the deal by rotating out of other growth names. See the premarket setup: briefing.com/stock-market-up… $SPY $QQQ $DIA $USO $TNX $SMH $SPCX $LEN $ADBE #Oil #SpaceX #IPO #geopolitics #growthstocks #tech #markets #premarket #analysis #Investing
581
Gapping up: $SATS 7% $NBIS 5.5% $RKLB 5.5% $ALAB 5.5% $CRWV 5.2% Gapping down: $MBX -29% $SPCE -9.7% $COE -7.1% $ADBE -7.1%
1
4
836
$ORCL: Oracle (-11.3%) is selling off despite strong EPS upside and huge AI demand proof points, including $638 bln in RPO and 93% cloud infrastructure growth. The issue is the bar: reaffirmed FY27 revenue guidance and a coming gross margin step-down were not enough for a stock priced for accelerating AI upside. See the full analysis: briefing.com/story-stocks/ar… #Oracle #earnings #AI #CloudComputing #techstocks #stocks #storystocks
1
782
$INTC: Intel ( 4.1%) upgraded to Buy from Underperform at BofA Securities, tgt $135 briefing.com/calendars/updow…

1
893
$ORCL: Oracle (-10.1%) beats by $0.15, reports revs in-line; guides Q1 EPS above consensus, revs in-line; guides FY27 EPS above consensus, reaffirms FY27 revs guidance; expects to raise approximately $40 bln through a combination of debt and equity financing, including its previously announced $20 bln at-the-market equity issuance.
1
907
Futures are rebounding as tech and semis try to recover from another intraday selloff, but follow-through is the test. $ORCL’s post-earnings slide and AI financing concerns keep the bar high ahead of today’s PPI report. Read the premarket setup: briefing.com/stock-market-up… $SPY $QQQ $DIA $TNX $SMH $USO $INTC #tech #oil #Iran #semiconductors #geopolitics #markets #PPI #CPI #macro #premarket #stockmarket #marketupdate
1
1
881
$HUMA: Humacyte (-20.9%) trading lower premarket after announcing top-line interim results for the V012 Phase 3 study and pricing an offering of 47,619,048 shares of common stock at $1.05/share.
996
Gapping up: $NAVN 24.8% $MBAV 12.4% $CPOP 11.8% $ISOU 4.6% $UUUU 3.8% Gapping down: $HUMA -18.7% $OXM -13.9% $PCT -15% $ORCL -9.4%
1
4
948
$CASY: Casey’s is soaring after a strong Q4 beat, constructive FY27 targets, a bigger buyback program, and a 14% dividend hike. The key read is quality: inside comps accelerated to 5.5%, driven mostly by traffic, while margins held above 42%. See the full analysis: briefing.com/story-stocks/ar… #earnings #Retail #Stocks #conveniencestore #fuel #investing
2
919
$TSM: Taiwan Semi’s May revenue keeps the company tracking well against Q2 guidance and reinforces the strength of AI, HPC, and advanced-node demand. The question is whether that visibility can keep supporting the stock when expectations, capex, and broader semiconductor weakness are already elevated. See the full analysis: briefing.com/story-stocks/ar… #semiconductors #ChipStocks #AI #tech #AIInfrastructure #Investing #stocks #storystocks
1
880